In developed countries, breastfeeding is not recommended for women living with human immunodeficiency virus (WLWH). However, lactation symptoms can be distressing for women who choose not to breastfeed.
There is currently no universal guideline on the most appropriate options for prevention or reduction of lactation symptoms amongst WLWH. This review describes the evidence base for using cabergoline, a dopaminergic agonist, for the post-partum inhibition of lactation for WLWH.
ADAMTS18 Antibody |
1-CSB-PA493628 |
Cusabio |
|
|
|
Description: A polyclonal antibody against ADAMTS18. Recognizes ADAMTS18 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC-p:1:100-1:300.ELISA:1/10000 |
ADAMTS18 Antibody |
34387-100ul |
SAB |
100ul |
EUR 252 |
ADAMTS18 Antibody |
34387-50ul |
SAB |
50ul |
EUR 187 |
ADAMTS18 siRNA |
20-abx906758 |
Abbexa |
|
|
|
ADAMTS18 siRNA |
20-abx906759 |
Abbexa |
|
|
|
ADAMTS18 Antibody |
DF3740 |
Affbiotech |
200ul |
EUR 304 |
Description: ADAMTS18 Antibody detects endogenous levels of total ADAMTS18. |
anti-ADAMTS18 |
YF-PA22638 |
Abfrontier |
50 ug |
EUR 363 |
Description: Mouse polyclonal to ADAMTS18 |
ADAMTS18 antibody |
70R-33996 |
Fitzgerald |
100 ug |
EUR 327 |
Description: Rabbit polyclonal ADAMTS18 antibody |
ADAMTS18 antibody |
70R-4602 |
Fitzgerald |
50 ug |
EUR 467 |
Description: Rabbit polyclonal ADAMTS18 antibody raised against the N terminal of ADAMTS18 |
ADAMTS18 cloning plasmid |
CSB-CL851556HU-10ug |
Cusabio |
10ug |
EUR 1294 |
|
Description: A cloning plasmid for the ADAMTS18 gene. |
ADAMTS18 Blocking Peptide |
20-abx161008 |
Abbexa |
|
|
|
ADAMTS18 Conjugated Antibody |
C34387 |
SAB |
100ul |
EUR 397 |
ADAMTS18 Blocking Peptide |
DF3740-BP |
Affbiotech |
1mg |
EUR 195 |
ADAMTS18 Blocking Peptide |
33R-3140 |
Fitzgerald |
100 ug |
EUR 180 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ADAMTS18 antibody, catalog no. 70R-4602 |
Human ADAMTS18 shRNA Plasmid |
20-abx966125 |
Abbexa |
|
|
|
Mouse ADAMTS18 shRNA Plasmid |
20-abx980584 |
Abbexa |
|
|
|
ADAMTS18 ELISA Kit (Human) (OKEH01736) |
OKEH01736 |
Aviva Systems Biology |
96 Wells |
EUR 727 |
Description: Description of target: This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. ADAMTS family members share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The protein encoded by this gene has a high sequence similarity to the protein encoded by gene ADAMTS16, another family member. It is thought to function as a tumor suppressor. Alternatively spliced transcript variants have been identified, but their biological validity has not been determined.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 34 pg/mL |
ADAMTS18 ELISA Kit (Mouse) (OKEH05099) |
OKEH05099 |
Aviva Systems Biology |
96 Wells |
EUR 727 |
Description: Description of target: ;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 39.2 pg/mL |
ADAMTS18 ORF Vector (Human) (pORF) |
ORF000179 |
ABM |
1.0 ug DNA |
EUR 95 |
Adamts18 ORF Vector (Mouse) (pORF) |
ORF038104 |
ABM |
1.0 ug DNA |
EUR 506 |
Adamts18 ORF Vector (Rat) (pORF) |
ORF063066 |
ABM |
1.0 ug DNA |
EUR 506 |
ADAMTS18 sgRNA CRISPR Lentivector set (Human) |
K0045201 |
ABM |
3 x 1.0 ug |
EUR 339 |
Adamts18 sgRNA CRISPR Lentivector set (Rat) |
K6191801 |
ABM |
3 x 1.0 ug |
EUR 339 |
Adamts18 sgRNA CRISPR Lentivector set (Mouse) |
K3868201 |
ABM |
3 x 1.0 ug |
EUR 339 |
ADAMTS18 sgRNA CRISPR Lentivector (Human) (Target 1) |
K0045202 |
ABM |
1.0 ug DNA |
EUR 154 |
ADAMTS18 sgRNA CRISPR Lentivector (Human) (Target 2) |
K0045203 |
ABM |
1.0 ug DNA |
EUR 154 |
ADAMTS18 sgRNA CRISPR Lentivector (Human) (Target 3) |
K0045204 |
ABM |
1.0 ug DNA |
EUR 154 |
Adamts18 sgRNA CRISPR Lentivector (Rat) (Target 1) |
K6191802 |
ABM |
1.0 ug DNA |
EUR 154 |
Adamts18 sgRNA CRISPR Lentivector (Rat) (Target 2) |
K6191803 |
ABM |
1.0 ug DNA |
EUR 154 |
Adamts18 sgRNA CRISPR Lentivector (Rat) (Target 3) |
K6191804 |
ABM |
1.0 ug DNA |
EUR 154 |
Adamts18 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
K3868202 |
ABM |
1.0 ug DNA |
EUR 154 |
Adamts18 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
K3868203 |
ABM |
1.0 ug DNA |
EUR 154 |
Adamts18 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
K3868204 |
ABM |
1.0 ug DNA |
EUR 154 |
ADAMTS18 Protein Vector (Human) (pPB-His-MBP) |
PV319866 |
ABM |
500 ng |
EUR 329 |
ADAMTS18 Protein Vector (Human) (pPB-His-GST) |
PV319867 |
ABM |
500 ng |
EUR 329 |
ADAMTS18 Protein Vector (Rat) (pPB-C-His) |
PV252262 |
ABM |
500 ng |
EUR 1166 |
ADAMTS18 Protein Vector (Rat) (pPB-N-His) |
PV252263 |
ABM |
500 ng |
EUR 1166 |
ADAMTS18 Protein Vector (Rat) (pPM-C-HA) |
PV252264 |
ABM |
500 ng |
EUR 1166 |
ADAMTS18 Protein Vector (Rat) (pPM-C-His) |
PV252265 |
ABM |
500 ng |
EUR 1166 |
ADAMTS18 Protein Vector (Human) (pPB-C-His) |
PV000713 |
ABM |
500 ng |
EUR 329 |
ADAMTS18 Protein Vector (Human) (pPB-N-His) |
PV000714 |
ABM |
500 ng |
EUR 329 |
ADAMTS18 Protein Vector (Human) (pPM-C-HA) |
PV000715 |
ABM |
500 ng |
EUR 329 |
ADAMTS18 Protein Vector (Human) (pPM-C-His) |
PV000716 |
ABM |
500 ng |
EUR 329 |
Adamts18 3'UTR Luciferase Stable Cell Line |
TU101393 |
ABM |
1.0 ml |
Ask for price |
ADAMTS18 Protein Vector (Mouse) (pPB-C-His) |
PV152414 |
ABM |
500 ng |
EUR 1065 |
ADAMTS18 Protein Vector (Mouse) (pPB-N-His) |
PV152415 |
ABM |
500 ng |
EUR 1065 |
ADAMTS18 Protein Vector (Mouse) (pPM-C-HA) |
PV152416 |
ABM |
500 ng |
EUR 1065 |
ADAMTS18 Protein Vector (Mouse) (pPM-C-His) |
PV152417 |
ABM |
500 ng |
EUR 1065 |
Adamts18 3'UTR GFP Stable Cell Line |
TU250277 |
ABM |
1.0 ml |
Ask for price |
Adamts18 3'UTR Luciferase Stable Cell Line |
TU200277 |
ABM |
1.0 ml |
Ask for price |
ADAMTS18 3'UTR GFP Stable Cell Line |
TU050332 |
ABM |
1.0 ml |
EUR 4617 |
Adamts18 3'UTR GFP Stable Cell Line |
TU151393 |
ABM |
1.0 ml |
Ask for price |
ADAMTS18 3'UTR Luciferase Stable Cell Line |
TU000332 |
ABM |
1.0 ml |
EUR 4617 |
ADAMTS18 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
LV650521 |
ABM |
1.0 ug DNA |
EUR 1355 |
ADAMTS18 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
LV650525 |
ABM |
1.0 ug DNA |
EUR 1355 |
ADAMTS18 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
LV650526 |
ABM |
1.0 ug DNA |
EUR 1355 |
Adamts18 ELISA Kit| Mouse A disintegrin and metalloproteinase w |
EF014135 |
Lifescience Market |
96 Tests |
EUR 689 |
ADAMTS18 Protein Vector (Human) (pPM-N-D-C-HA) |
PV319868 |
ABM |
500 ng |
EUR 329 |
ADAMTS18 Protein Vector (Human) (pPM-N-D-C-His) |
PV319869 |
ABM |
500 ng |
EUR 329 |
Human A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAMTS18) |
1-CSB-EP851556HU |
Cusabio |
-
EUR 505.00
-
EUR 265.00
-
EUR 1827.00
-
EUR 766.00
-
EUR 1218.00
-
EUR 335.00
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human A disintegrin and metalloproteinase with thrombospondin motifs 18(ADAMTS18),partial expressed in E.coli |
ADAM Metallopeptidase With Thrombospondin Type 1 Motif 18 (ADAMTS18) Antibody |
20-abx121008 |
Abbexa |
-
EUR 300.00
-
EUR 439.00
-
EUR 189.00
|
|
|
ADAM Metallopeptidase With Thrombospondin Type 1 Motif 18 (ADAMTS18) Antibody |
abx038097-100ug |
Abbexa |
100 ug |
EUR 391 |
|
ADAM Metallopeptidase With Thrombospondin Type 1 Motif 18 (ADAMTS18) Antibody |
20-abx014155 |
Abbexa |
-
EUR 314.00
-
EUR 98.00
-
EUR 398.00
-
EUR 495.00
|
- 100 ug
- 10 ug
- 200 ug
- 300 µg
|
|
ADAM Metallopeptidase With Thrombospondin Type 1 Motif 18 (ADAMTS18) Antibody |
20-abx212832 |
Abbexa |
|
|
|
ADAM Metallopeptidase With Thrombospondin Type 1 Motif 18 (ADAMTS18) Antibody |
20-abx212036 |
Abbexa |
|
|
|
ADAM Metallopeptidase With Thrombospondin Type 1 Motif 18 (ADAMTS18) Antibody |
abx331727-100ul |
Abbexa |
100 ul |
EUR 425 |
|
ADAM Metallopeptidase With Thrombospondin Type 1 Motif 18 (ADAMTS18) Antibody |
20-abx326245 |
Abbexa |
|
|
|
ADAMTS18 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
K0045205 |
ABM |
3 x 1.0 ug |
EUR 376 |
Adamts18 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
K6191805 |
ABM |
3 x 1.0 ug |
EUR 376 |
Adamts18 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
K3868205 |
ABM |
3 x 1.0 ug |
EUR 376 |
ADAMTS18 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
K0045206 |
ABM |
1.0 ug DNA |
EUR 167 |
ADAMTS18 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
K0045207 |
ABM |
1.0 ug DNA |
EUR 167 |
ADAMTS18 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
K0045208 |
ABM |
1.0 ug DNA |
EUR 167 |
ADAMTS18 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA) |
LV650522 |
ABM |
1.0 ug DNA |
EUR 1355 |
ADAMTS18 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
LV650523 |
ABM |
1.0 ug DNA |
EUR 1413 |
ADAMTS18 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
LV650524 |
ABM |
1.0 ug DNA |
EUR 1413 |
Adamts18 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
K6191806 |
ABM |
1.0 ug DNA |
EUR 167 |
Adamts18 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
K6191807 |
ABM |
1.0 ug DNA |
EUR 167 |
Adamts18 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
K6191808 |
ABM |
1.0 ug DNA |
EUR 167 |
Adamts18 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
K3868206 |
ABM |
1.0 ug DNA |
EUR 167 |
Adamts18 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
K3868207 |
ABM |
1.0 ug DNA |
EUR 167 |
Adamts18 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
K3868208 |
ABM |
1.0 ug DNA |
EUR 167 |
Human A disintegrin and metalloproteinase with thrombospondin motifs 18(ADAMTS18) ELISA kit |
CSB-EL001306HU-24T |
Cusabio |
1 plate of 24 wells |
EUR 165 |
|
Description: Quantitativesandwich ELISA kit for measuring Human A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAMTS18) in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Human A disintegrin and metalloproteinase with thrombospondin motifs 18(ADAMTS18) ELISA kit |
1-CSB-EL001306HU |
Cusabio |
-
EUR 804.00
-
EUR 5099.00
-
EUR 2704.00
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
Description: Quantitativesandwich ELISA kit for measuring Human A disintegrin and metalloproteinase with thrombospondin motifs 18(ADAMTS18) in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
ELISA kit for Human ADAMTS18 (A Disintegrin And Metalloproteinase With Thrombospondin 18) |
E-EL-H5602 |
Elabscience Biotech |
1 plate of 96 wells |
EUR 534 |
|
Description: A sandwich ELISA kit for quantitative measurement of Human ADAMTS18 (A Disintegrin And Metalloproteinase With Thrombospondin 18) in samples from Serum, Plasma, Cell supernatant |
Mouse Adamts18/ A disintegrin and metalloproteinase with thrombospondin motifs 18 ELISA Kit |
E0034Mo |
Sunlong |
1 Kit |
EUR 632 |
Human ADAMTS18/ A disintegrin and metalloproteinase with thrombospondin motifs 18 ELISA Kit |
E0052Hu |
Sunlong |
1 Kit |
EUR 605 |
Human ADAM Metallopeptidase With Thrombospondin Type 1 Motif 18 (ADAMTS18) ELISA Kit |
abx520409-96tests |
Abbexa |
96 tests |
EUR 754 |
|
Mouse ADAM Metallopeptidase With Thrombospondin Type 1 Motif 18 (ADAMTS18) ELISA Kit |
abx520410-96tests |
Abbexa |
96 tests |
EUR 668 |
|
Human ADAM Metallopeptidase With Thrombospondin Type 1 Motif 18 (ADAMTS18) ELISA Kit |
abx251648-96tests |
Abbexa |
96 tests |
EUR 754 |
|
Human ADAMTS18(A disintegrin and metalloproteinase with thrombospondin motifs 18) ELISA Kit |
EH2297 |
FN Test |
96T |
EUR 567.6 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 46.9pg/ml |
A scoping review of post-partum pharmaceutical lactation inhibition specific for WLWH was conducted using searches in PubMed, Medline Ovid, EBM Reviews Ovid, Embase, Web of Science and Scopus until 2019.
A narrative review of cabergoline pharmacologic properties, therapeutic efficacy, tolerability data and drug interaction data relevant to lactation inhibition was then conducted. Among 1366 articles, the scoping review identified 13 relevant publications.
Eight guidelines providing guidance regarding lactation inhibition for WLWH and two surveys of medical practice on this topic in UK have been published.